Heron Therapeutics to cut about one-third of its workforce as part of cost-cutting plan
Heron Therapeutics Inc. said Thursday it will lay off about one-third of its workforce as part of a restructuring expected to save $43 million a...
Blueprint inks deal with Sixth Street, Royalty Pharma worth up to $1.2 billion
Shares of Blueprint Medicines Corp. gained 3.3% in premarket trading on Thursday after the company announced a deal with investment firm Sixth Street and Royalty...
Aura’s stock jumps 11% after announcing Fast Track status for its bladder cancer treatment candidate
Shares of Aura Biosciencs Inc. were up 11.3% in premarket trading on Thursday after the company said it received a Fast-Track designation from the Food...
Constellation Brands plan to eliminate Class B stock would boost Class A shares outstanding by about 14%
Constellation Brands Inc. said Thursday it will seek shareholder approval to eliminate its higher-vote Class B shares, which would end the associated voting control of...
Canopy Growth shares fall after it agrees to convert debt into stock in deal with Constellation Brands
Canopy Growth Corp. fell 17% in premarket trades on Thursday after the company said it reached an agreement with Constellation Brands Inc. to convert about...
Stocks open sharply lower as S&P 500 heads for worst start to a year since 1970
Stocks opened sharply lower Wednesday, on track to cap a brutal first half for equities that has the S&P 500 on pace for its worst...
Biden says he supports Senate filibuster ‘exception’ for abortion rights
President Joe Biden called on Congress Thursday to pass a law codifying abortion rights for all Americans, and he argued the Senate should create an...
All 30 Dow stocks are falling, with Goldman Sachs and Salesforce the biggest drags
The Dow Jones Industrial Average's is suffering a unanimous decline of 480 points, or 1.6%, as all 30 of the blue-chip barometer's components are trading...
RH stock slumps after downward guidance revision, analyst price target cuts
RH shares dropped 11.7% in early Thursday trading following an after-hours downward guidance revision and subsequent analyst price target cuts. The stock has declined 21%...